The tweet was deleted by the author.
But we saved everything 🙂.
Candel Therapeutics, Inc. announced that its Chief Regulatory Officer, Susan Stewart, J.D., has been named to the RAPSorg 50 for 50 list, which honors outstanding regulatory professionals as part of the Regulatory Affairs Professionals Society’s 50th anniversary.
The company praised Stewart’s expertise as a critical factor in advancing its regulatory strategy. RAPSorg’s annual recognition highlights the industry’s leading experts in regulatory affairs, underscoring the importance of leadership in advancing healthcare compliance and innovation.
Candel Therapeutics has recently advanced its focus on viral immunotherapies targeting prostate, lung, and brain cancers, according to a research update. The company’s leadership has also advocated for development of targeted oncology therapies in industry discussions. These efforts align with the company’s ongoing commitment to scientific and regulatory progress.